keep on radar and watch for breakout.
I recently got new contact lenses and my optometrist; Columbia MD!! said he is pushing Cooper Vision products because patients are having better comfort experiences over JnJ products.
I'm reading a research report and Wells Fargo basically echoes this due diligence.
i am a technical trader but its obvious the fundamentals are good and the chart looks primed for momentum.
>>yes I am long. If you want to take the other side, please post your shorts.
I recently got new contact lenses and my optometrist; Columbia MD!! said he is pushing Cooper Vision products because patients are having better comfort experiences over JnJ products.
I'm reading a research report and Wells Fargo basically echoes this due diligence.
We recommend investors buy COO shares on the weakness because our recent channel checks confirm that COO is outpacing the overall contact lens market due to its new product launches. Our recent channel checks confirm that COO is growing faster than the market because of their new products. We have heard that COOâs share is increasing among independent eye care practitioners (ECP) who account for about 75% of prescriptions but only about 60% of contact lens sales. As COOâs share increases among independents, its share should increase among mass and Internet retailers because many consumers tend to re-fill their prescriptions at those outlets. In addition, the recent Luxottica Product of Choice deal should add $5MM-$10MM in sales in 2010. COOâs contact lens business grew +5% constant currency in C4Q 2009 vs +4% for the market and COO's contact lens business grew +8% cc in F1Q 2010 which implies that its growth rate accelerated in January 2010.
i am a technical trader but its obvious the fundamentals are good and the chart looks primed for momentum.
>>yes I am long. If you want to take the other side, please post your shorts.
